Function of the Plasminogen/Plasmin and Matrix Metalloproteinase Systems After Vascular Injury in Mice With Targeted Inactivation of Fibrinolytic System Genes

From the Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium (H.R.L., B.V.H., D.C.); the Vascular Biology Laboratory, Thrombosis Research Institute, London, UK (F.L.); and the Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium (L.M., P.C., D.C.).

Correspondence to H. Roger Lijnen, Center for Molecular and Vascular Biology, KU Leuven, Campus Gasthuisberg, O&N, Herestraat 49, B-3000 Leuven, Belgium. E-mail roger.lijnen{at}med.kuleuven.ac.be

Abstract—The matrix metalloproteinase (MMP) system, which may be activated via the plasminogen (Plg)/plasmin system, is claimed to play a role in matrix degradation and smooth muscle cell migration. To test the role of both systems, expression of fibrinolytic and gelatinolytic activity was quantified after vascular injury in mice with targeted inactivation of tissue-type Plg activator (tPA^-/-), urokinase-type Plg activator (uPA^-/-), or Plg (Plg^-/-). Neointima formation 1 week after vascular injury was impaired in uPA^-/- and Plg^-/- mice compared with wild-type (WT) mice or tPA^-/- mice (reduction of neointimal area to 30% and 10% of WT, respectively). Cell accumulation at the borders of the injury was significantly (P<0.01) impaired compared with that in WT mice. One week after injury of the femoral artery, tPA-mediated fibrinolytic activity in arterial sections or extracts of WT, uPA^-/-, or Plg^-/- mice was not altered, whereas uPA activity levels in tPA^-/- and Plg^-/- mice were 2- to 3-fold higher than in uninjured controls. Total levels (latent plus active) of MMP-2 (gelatinase A) were increased by 2- to 4-fold, whereas the contribution of active MMP-2 represented 38% to 63% of the total in the different genotypes. MMP-9 (gelatinase B) was not detectable in the majority of control arteries, whereas total MMP-9 levels after injury were dramatically increased (up to 50-fold above the detection limit). Active MMP-9 represented 20% to 46% of total MMP-9 in WT, tPA^-/-, and uPA^-/- mice but was not consistently detectable in Plg^-/- mice. Similar results were obtained in carotid arteries. Thus, the unaltered ratios of active and latent MMP-2 suggest that proMMP-2 activation may occur in the absence of tPA, uPA, or Plg, whereas no active MMP-9 was detected in the absence of Plg. The data of this study confirm a role for uPA and Plg but not for tPA in smooth muscle cell migration and neointima formation after vascular injury and indicate that impairment of these phenomena may occur despite the observed increases in MMP-2 or MMP-9 levels after vascular injury.

Key Words: neointima • restenosis • transgenic mice • gelatinase • fibrinolysis

This article has been cited by other articles:

				M. KARALAKI, S. FILI, A. PHILIPPOU, and M. KOUTSILIERIS Muscle Regeneration: Cellular and Molecular Events In Vivo, September 1, 2009; 23(5): 779 - 796. [Abstract] [Full Text] [PDF]

				K. Lehti, N. F. Rose, S. Valavaara, S. J. Weiss, and J. Keski-Oja MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing J. Cell Sci., January 1, 2009; 122(1): 126 - 135. [Abstract] [Full Text] [PDF]

				A. Dwivedi, S. C. Slater, and S. J. George MMP-9 and -12 cause N-cadherin shedding and thereby {beta}-catenin signalling and vascular smooth muscle cell proliferation Cardiovasc Res, January 1, 2009; 81(1): 178 - 186. [Abstract] [Full Text] [PDF]

				F. Mannello Serum or Plasma Samples?: The "Cinderella" Role of Blood Collection Procedures Preanalytical Methodological Issues Influence the Release and Activity of Circulating Matrix Metalloproteinases and Their Tissue Inhibitors, Hampering Diagnostic Trueness and Leading to Misinterpretation Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 611 - 614. [Full Text] [PDF]

				S.K. Payeli, R. Latini, C. Gebhard, A. Patrignani, U. Wagner, T.F. Luscher, and F.C. Tanner Prothrombotic Gene Expression Profile in Vascular Smooth Muscle Cells of Human Saphenous Vein, but Not Internal Mammary Artery Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 705 - 710. [Abstract] [Full Text] [PDF]

				H. Hlawaty, A. San Juan, M.-P. Jacob, R. Vranckx, D. Letourneur, and L. J. Feldman Inhibition of MMP-2 gene expression with small interfering RNA in rabbit vascular smooth muscle cells Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3593 - H3601. [Abstract] [Full Text] [PDF]

				K. Shimada, M. Nakamura, E. Ishida, T. Higuchi, M. Tanaka, I. Ota, and N. Konishi c-Jun NH2 Terminal Kinase Activation and Decreased Expression of Mitogen-Activated Protein Kinase Phosphatase-1 Play Important Roles in Invasion and Angiogenesis of Urothelial Carcinomas Am. J. Pathol., September 1, 2007; 171(3): 1003 - 1012. [Abstract] [Full Text] [PDF]

				E. Dai, K. Viswanathan, Y. M. Sun, X. Li, L. Y. Liu, B. Togonu-Bickersteth, J. Richardson, C. Macaulay, P. Nash, P. Turner, et al. Identification of Myxomaviral Serpin Reactive Site Loop Sequences That Regulate Innate Immune Responses J. Biol. Chem., March 24, 2006; 281(12): 8041 - 8050. [Abstract] [Full Text] [PDF]

				J. J.T.H. Roelofs, K. M.A. Rouschop, J. C. Leemans, N. Claessen, A. M. de Boer, W. M. Frederiks, H.R. Lijnen, J. J. Weening, and S. Florquin Tissue-Type Plasminogen Activator Modulates Inflammatory Responses and Renal Function in Ischemia Reperfusion Injury J. Am. Soc. Nephrol., January 1, 2006; 17(1): 131 - 140. [Abstract] [Full Text] [PDF]

				S. Filippov, G. C. Koenig, T.-H. Chun, K. B. Hotary, I. Ota, T. H. Bugge, J. D. Roberts, W. P. Fay, H. Birkedal-Hansen, K. Holmbeck, et al. MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells J. Exp. Med., September 6, 2005; 202(5): 663 - 671. [Abstract] [Full Text] [PDF]

				X. W. Cheng, M. Kuzuya, K. Nakamura, Z. Liu, Q. Di, J. Hasegawa, M. Iwata, T. Murohara, M. Yokota, and A. Iguchi Mechanisms of the Inhibitory Effect of Epigallocatechin-3-Gallate on Cultured Human Vascular Smooth Muscle Cell Invasion Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1864 - 1870. [Abstract] [Full Text] [PDF]

				G. Xiang, M. D. Schuster, T. Seki, P. Witkowski, S. Eshghi, and S. Itescu Downregulated Expression of Plasminogen Activator Inhibitor-1 Augments Myocardial Neovascularization and Reduces Cardiomyocyte Apoptosis After Acute Myocardial Infarction J. Am. Coll. Cardiol., August 2, 2005; 46(3): 536 - 541. [Abstract] [Full Text] [PDF]

				G. Xiang, M. D. Schuster, T. Seki, A. A. Kocher, S. Eshghi, A. Boyle, and S. Itescu Down-regulation of Plasminogen Activator Inhibitor 1 Expression Promotes Myocardial Neovascularization by Bone Marrow Progenitors J. Exp. Med., December 20, 2004; 200(12): 1657 - 1666. [Abstract] [Full Text] [PDF]

				G. F. Hamann, D. Burggraf, H. K. Martens, M. Liebetrau, G. Jager, N. Wunderlich, M. DeGeorgia, and D. W. Krieger Mild to Moderate Hypothermia Prevents Microvascular Basal Lamina Antigen Loss in Experimental Focal Cerebral Ischemia Stroke, March 1, 2004; 35(3): 764 - 769. [Abstract] [Full Text] [PDF]

				C. Brownstein, A. B. Deora, A. T. Jacovina, R. Weintraub, M. Gertler, K. M. F. Khan, D. J. Falcone, and K. A. Hajjar Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages Blood, January 1, 2004; 103(1): 317 - 324. [Abstract] [Full Text] [PDF]

				P. E. Szmitko, C.-H. Wang, R. D. Weisel, G. A. Jeffries, T. J. Anderson, and S. Verma Biomarkers of Vascular Disease Linking Inflammation to Endothelial Activation: Part II Circulation, October 28, 2003; 108(17): 2041 - 2048. [Full Text] [PDF]

				S. Chuang-Tsai, T. H. Sisson, N. Hattori, C. G. Tsai, N. M. Subbotina, K. E. Hanson, and R. H. Simon Reduction in Fibrotic Tissue Formation in Mice Genetically Deficient in Plasminogen Activator Inhibitor-1 Am. J. Pathol., August 1, 2003; 163(2): 445 - 452. [Abstract] [Full Text] [PDF]

				E. Dai, H. Guan, L. Liu, S. Little, G. McFadden, S. Vaziri, H. Cao, I. A. Ivanova, L. Bocksch, and A. Lucas Serp-1, a Viral Anti-inflammatory Serpin, Regulates Cellular Serine Proteinase and Serpin Responses to Vascular Injury J. Biol. Chem., May 9, 2003; 278(20): 18563 - 18572. [Abstract] [Full Text] [PDF]

				A. T. Askari, M.-L. Brennan, X. Zhou, J. Drinko, A. Morehead, J. D. Thomas, E. J. Topol, S. L. Hazen, and M. S. Penn Myeloperoxidase and Plasminogen Activator Inhibitor 1 Play a Central Role in Ventricular Remodeling after Myocardial Infarction J. Exp. Med., March 3, 2003; 197(5): 615 - 624. [Abstract] [Full Text] [PDF]

				H. R. Lijnen, E. Maquoi, P. Morange, G. Voros, B. Van Hoef, F. Kopp, D. Collen, I. Juhan-Vague, and M.-C. Alessi Nutritionally Induced Obesity Is Attenuated in Transgenic Mice Overexpressing Plasminogen Activator Inhibitor-1 Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 78 - 84. [Abstract] [Full Text] [PDF]

				S. Konstantinides, K. Schafer, and D. J. Loskutoff Do PAI-1 and Vitronectin Promote or Inhibit Neointima Formation?: The Exact Role of the Fibrinolytic System in Vascular Remodeling Remains Uncertain Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 1943 - 1945. [Full Text] [PDF]

				S. K. Chintala, X. Zhang, J. S. Austin, and M. E. Fini Deficiency in Matrix Metalloproteinase Gelatinase B (MMP-9) Protects against Retinal Ganglion Cell Death after Optic Nerve Ligation J. Biol. Chem., November 27, 2002; 277(49): 47461 - 47468. [Abstract] [Full Text] [PDF]

				S. Netzel-Arnett, D. J. Mitola, S. S. Yamada, K. Chrysovergis, K. Holmbeck, H. Birkedal-Hansen, and T. H. Bugge Collagen Dissolution by Keratinocytes Requires Cell Surface Plasminogen Activation and Matrix Metalloproteinase Activity J. Biol. Chem., November 15, 2002; 277(47): 45154 - 45161. [Abstract] [Full Text] [PDF]

				S. V. Brodsky, K. Malinowski, M. Golightly, J. Jesty, and M. S. Goligorsky Plasminogen Activator Inhibitor-1 Promotes Formation of Endothelial Microparticles With Procoagulant Potential Circulation, October 29, 2002; 106(18): 2372 - 2378. [Abstract] [Full Text] [PDF]

				F. G. Bannach, A. Gutierrez, B. J. Fowler, T. H. Bugge, J. L. Degen, R. J. Parmer, and L. A. Miles Localization of Regulatory Elements Mediating Constitutive and Cytokine-stimulated Plasminogen Gene Expression J. Biol. Chem., October 4, 2002; 277(41): 38579 - 38588. [Abstract] [Full Text] [PDF]

				K. Schafer, S. Konstantinides, C. Riedel, T. Thinnes, K. Muller, C. Dellas, G. Hasenfuss, and D. J. Loskutoff Different Mechanisms of Increased Luminal Stenosis After Arterial Injury in Mice Deficient for Urokinase- or Tissue-Type Plasminogen Activator Circulation, October 1, 2002; 106(14): 1847 - 1852. [Abstract] [Full Text] [PDF]

				D. G. Kuhel, B. Zhu, D. P. Witte, and D. Y. Hui Distinction in Genetic Determinants for Injury-Induced Neointimal Hyperplasia and Diet-Induced Atherosclerosis in Inbred Mice Arterioscler Thromb Vasc Biol, June 1, 2002; 22(6): 955 - 960. [Abstract] [Full Text] [PDF]

				J. Silence, D. Collen, and H.R. Lijnen Reduced Atherosclerotic Plaque but Enhanced Aneurysm Formation in Mice With Inactivation of the Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Gene Circ. Res., May 3, 2002; 90(8): 897 - 903. [Abstract] [Full Text] [PDF]

				M. P.D. Dow, L. J. Bakke, C. A. Cassar, M. W. Peters, J. R. Pursley, and G. W. Smith Gonadotropin Surge-Induced Up-Regulation of the Plasminogen Activators (Tissue Plasminogen Activator and Urokinase Plasminogen Activator) and the Urokinase Plasminogen Activator Receptor Within Bovine Periovulatory Follicular and Luteal Tissue Biol Reprod, May 1, 2002; 66(5): 1413 - 1421. [Abstract] [Full Text]

				M. Wang and E. G. Lakatta Altered Regulation of Matrix Metalloproteinase-2 in Aortic Remodeling During Aging Hypertension, April 1, 2002; 39(4): 865 - 873. [Abstract] [Full Text] [PDF]

				H.R. Lijnen, E. Maquoi, L.B. Hansen, B. Van Hoef, L. Frederix, and D. Collen Matrix Metalloproteinase Inhibition Impairs Adipose Tissue Development in Mice Arterioscler Thromb Vasc Biol, March 1, 2002; 22(3): 374 - 379. [Abstract] [Full Text] [PDF]

				T. Teesalu, A. E. Hinkkanen, and A. Vaheri Coordinated Induction of Extracellular Proteolysis Systems During Experimental Autoimmune Encephalomyelitis in Mice Am. J. Pathol., December 1, 2001; 159(6): 2227 - 2237. [Abstract] [Full Text] [PDF]

				L. J. Feldman, M. Mazighi, A. Scheuble, J.-F. Deux, E. De Benedetti, C. Badier-Commander, E. Brambilla, D. Henin, P. G. Steg, and M.-P. Jacob Differential Expression of Matrix Metalloproteinases After Stent Implantation and Balloon Angioplasty in the Hypercholesterolemic Rabbit Circulation, June 26, 2001; 103(25): 3117 - 3122. [Abstract] [Full Text] [PDF]

				D. J. Webb, K. S. Thomas, and S. L. Gonias Plasminogen Activator Inhibitor 1 Functions as a Urokinase Response Modifier at the Level of Cell Signaling and Thereby Promotes Mcf-7 Cell Growth J. Cell Biol., February 19, 2001; 152(4): 741 - 752. [Abstract] [Full Text] [PDF]

				T. L. Frandsen, C. Holst-Hansen, B. S. Nielsen, I. J. Christensen, J. R. Nyengaard, P. Carmeliet, and N. Brünner Direct Evidence of the Importance of Stromal Urokinase Plasminogen Activator (uPA) in the Growth of an Experimental Human Breast Cancer Using a Combined uPA Gene-Disrupted and Immunodeficient Xenograft Model Cancer Res., January 1, 2001; 61(2): 532 - 537. [Abstract] [Full Text]

				D. Godin, E. Ivan, C. Johnson, R. Magid, and Z. S. Galis Remodeling of Carotid Artery Is Associated With Increased Expression of Matrix Metalloproteinases in Mouse Blood Flow Cessation Model Circulation, December 5, 2000; 102(23): 2861 - 2866. [Abstract] [Full Text] [PDF]

				A. HAJ-YEHIA, T. NASSAR, B. S. SACHAIS, A. KUO, K. BDEIR, A. B. AL-MEHDI, A. MAZAR, D. B. CINES, and A. A.-R. HIGAZI Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo FASEB J, July 1, 2000; 14(10): 1411 - 1422. [Abstract] [Full Text]

				E. Creemers, J. Cleutjens, J. Smits, S. Heymans, L. Moons, D. Collen, M. Daemen, and P. Carmeliet Disruption of the Plasminogen Gene in Mice Abolishes Wound Healing after Myocardial Infarction Am. J. Pathol., June 1, 2000; 156(6): 1865 - 1873. [Abstract] [Full Text] [PDF]

				P. E. Morange, H. R. Lijnen, M. C. Alessi, F. Kopp, D. Collen, and I. Juhan-Vague Influence of PAI-1 on Adipose Tissue Growth and Metabolic Parameters in a Murine Model of Diet-Induced Obesity Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1150 - 1154. [Abstract] [Full Text] [PDF]

				Y. Feng, J.-H. Yang, H. Huang, S. P. Kennedy, T. G. Turi, J. F. Thompson, P. Libby, and R. T. Lee Transcriptional Profile of Mechanically Induced Genes in Human Vascular Smooth Muscle Cells Circ. Res., December 3, 1999; 85(12): 1118 - 1123. [Abstract] [Full Text] [PDF]

				H. R. Lijnen, P. Soloway, and D. Collen Tissue Inhibitor of Matrix Metalloproteinases-1 Impairs Arterial Neointima Formation After Vascular Injury in Mice Circ. Res., December 3, 1999; 85(12): 1186 - 1191. [Abstract] [Full Text] [PDF]

				H. R. Lijnen, B. Van Hoef, I. Vanlinthout, M. Verstreken, M.-C. Rio, and D. Collen Accelerated Neointima Formation After Vascular Injury in Mice With Stromelysin-3 (MMP-11) Gene Inactivation Arterioscler Thromb Vasc Biol, December 1, 1999; 19(12): 2863 - 2870. [Abstract] [Full Text] [PDF]

				L. H Arroyo and R. T Lee Mechanisms of plaque rupture: mechanical and biologic interactions Cardiovasc Res, February 1, 1999; 41(2): 369 - 375. [Abstract] [Full Text] [PDF]

				S. Stefansson, E. Petitclerc, M. K. K. Wong, G. A. McMahon, P. C. Brooks, and D. A. Lawrence Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1 J. Biol. Chem., March 9, 2001; 276(11): 8135 - 8141. [Abstract] [Full Text] [PDF]

				X. Fu, S. Y. Kassim, W. C. Parks, and J. W. Heinecke Hypochlorous Acid Oxygenates the Cysteine Switch Domain of Pro-matrilysin (MMP-7). A MECHANISM FOR MATRIX METALLOPROTEINASE ACTIVATION AND ATHEROSCLEROTIC PLAQUE RUPTURE BY MYELOPEROXIDASE J. Biol. Chem., October 26, 2001; 276(44): 41279 - 41287. [Abstract] [Full Text] [PDF]

				J. Silence, D. Collen, and H.R. Lijnen Reduced Atherosclerotic Plaque but Enhanced Aneurysm Formation in Mice With Inactivation of the Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Gene Circ. Res., May 3, 2002; 90(8): 897 - 903. [Abstract] [Full Text] [PDF]